Redefining post-stress depression as a spatiotemporal five-disease multimorbidity trajectory: ghrelin-driven anchoring by Shugan absorbed compounds

Xi Huang , Runze Zhou , Chendong Xu , Haotian Qian , Yunke Huang , Zhan Gao , Qiulong Zhao , Min Xu , Shaoqi Shi , Ailing Yu , Jialing Zhou , Yaling Liu , Chenxiao Shan , Ping Ren

Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) : 1004159

PDF (10987KB)
Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) :1004159 DOI: 10.37349/ent.2026.1004159
Original Article
research-article
Redefining post-stress depression as a spatiotemporal five-disease multimorbidity trajectory: ghrelin-driven anchoring by Shugan absorbed compounds
Author information +
History +
PDF (10987KB)

Abstract

Aim: This study aimed to redefine post-stress depressive pathogenesis through a novel five-disease multimorbidity trajectory model (brain1-coronary-brain2-gastro-enteric; B1CB2GE) and to evaluate the multifunctional anchoring effects of Bupleurum chinense Shugan-San (BSS) and its absorbed compounds (ACs), including meranzin hydrate (MH), in AFS (acute forced swimming) male Sprague-Dawley rats. Methods: Temporal multimorbidity trajectories of B1CB2GE clusters were established in AFS rats and compared with single-disease models using 10 integrative analytic methods, including dynamic cluster trajectory modeling, biochemical profiling, and pharmacokinetic-pharmacodynamic (PK-PD) correlation analyses. A multi-cell experiment was used as a proxy for the in vivo system, whereas H-ECs (H2O2-treated endothelial cells) were used as a proxy for the multicellular system. Circulatory biomarkers related to oxidative, endothelial, and inflammatory (OEI) impairment, brain-derived neurotrophic factor (BDNF) levels, and cecal butyrate contents were measured. The role of the ghrelin (Ghr) receptor was examined using the antagonist D-Lys3-GHRP-6 (D-Lys). Forced-swim test, gastric emptying, enteric transit, and coronary flow were used to characterize post-AFS multimorbidity trajectory phenotypes in animals. Results: Fifteen minutes after AFS, distinct temporal B1CB2GE multimorbidity clusters emerged with normalized ranking values: G 15.31 > B2 1.17 > B1 0.85 > C 0.49 > E 0.32. These clusters were accurately anchored by BSS and its five tailored sets of 1–10 ACs, demonstrating multifunctional modulation ranging from 53.23% to 156.32%, with optimal anchoring efficiency of 96.37–104.14%. MH, a representative multifunctional compound, exhibited the strongest prokinetic and OEI-restorative effects, elevating BDNF and cecal butyrate levels. These therapeutic effects were abolished by D-Lys, confirming a Ghr-dependent mechanism. Conclusions: This study introduces a multimorbidity trajectory framework (B1CB2GE) for modeling post-stress depression and demonstrates that Shugan-like herbal formulas such as BSS effectively anchor dynamic multimorbidity progression via multifunctional compounds like MH. These findings provide a systems-pharmacology basis for understanding and treating complex comorbid depressive disorders through multifunctional anchoring herbal therapeutics.

Keywords

temporal multimorbidity trajectory / acute forced swim / normalization animal model / multifunction

Cite this article

Download citation ▾
Xi Huang, Runze Zhou, Chendong Xu, Haotian Qian, Yunke Huang, Zhan Gao, Qiulong Zhao, Min Xu, Shaoqi Shi, Ailing Yu, Jialing Zhou, Yaling Liu, Chenxiao Shan, Ping Ren. Redefining post-stress depression as a spatiotemporal five-disease multimorbidity trajectory: ghrelin-driven anchoring by Shugan absorbed compounds. Exploration of Neuroprotective Therapy, 2026, 6 (1) : 1004159 DOI:10.37349/ent.2026.1004159

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Huang X, Qin F, Zhang HM, Xiao HB, Wang LX, Zhang XY, et al. Cardioprotection by Guanxin II in rats with acute myocardial infarction is related to its three compounds. J Ethnopharmacol. 2009; 121: 268-73.

[2]

Huang X, Fan R, Zhang H, Ren P, Qing F, Wang Y. Bioethnopharmaceutical analytical pharmacology: a strategy for elucidating ethnoherbal absorbed bioactive compounds. Chin Tradit Herb Drugs. 2010; 41: 337-9.

[3]

Shi S, Yan H, Chen Y, Liu Y, Zhang X, Xie Y, et al. Pharmacokinetic study of precisely representative antidepressant, prokinetic, anti-inflammatory and anti-oxidative compounds from Fructus aurantii and Magnolia Bark. Chem Biol Interact. 2020; 315: 108851.

[4]

Huang X, Zhao Q, Xia L, Shi S. Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)' and 'Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.'. Pharmacol Res. 2021; 163: 105289.

[5]

Huang Y, Xu M, Li J, Chen K, Xia L, Wang W, et al. Ex vivo to in vivo extrapolation of syringic acid and ferulic acid as grape juice proxies for endothelium-dependent vasodilation: Redefining vasoprotective resveratrol of the French paradox. Food Chem. 2021; 363: 130323.

[6]

Zhang YJ, Huang X, Wang Y, Xie Y, Qiu XJ, Ren P, et al. Ferulic acid-induced anti-depression and prokinetics similar to Chaihu-Shugan-San via polypharmacology. Brain Res Bull. 2011; 86: 222-8.

[7]

Zhang YJ, Huang W, Huang X, Wang Y, Wang Z, Wang C, et al. Fructus Aurantii induced antidepressant effect via its monoaminergic mechanism and prokinetic action in rat. Phytomedicine. 2012; 19: 1101-7.

[8]

Xie Y, Huang X, Hu SY, Qiu XJ, Zhang YJ, Ren P, et al. Meranzin hydrate exhibits anti-depressive and prokinetic-like effects through regulation of the shared α2-adrenoceptor in the brain-gut axis of rats in the forced swimming test. Neuropharmacology. 2013; 67: 318-25.

[9]

Mu DZ, Xue M, Xu JJ, Hu Y, Chen Y, Ren P, et al. Antidepression and Prokinetic Effects of Paeoniflorin on Rats in the Forced Swimming Test via Polypharmacology. Evid Based Complement Alternat Med. 2016; 2016: 2153571.

[10]

Liu YL, Xu JJ, Han LR, Liu XF, Lin MH, Wang Y, et al. Meranzin Hydrate Improves Depression-Like Behaviors and Hypomotility via Ghrelin and Neurocircuitry. Chin J Integr Med. 2023; 29: 490-9.

[11]

Luo M, Huang X, Wang Y, Ren P. Zhiqiaochuanxiong decoction for major depressive disorder complicated by functional dyspepsia: a case report with fast-acting efficacy. J Tradit Chin Med. 2015; 35: 697-702.

[12]

Zhou RZ, Xu CD, Qian HT, Huang X. Ex vivo to in vivo extrapolation of primary absorbed compounds as multifunctional proxies of Zhiqiao (Fructus Aurantii Submaturus)-Houpo (Cortex Magnoliae Officinalis) herb pair. J Tradit Chin Med. 2026; 46: 51-61.

[13]

Liu Y, Wang W, Chen Y, Yan H, Wu D, Xu J, et al. Simultaneous quantification of nine components in the plasma of depressed rats after oral administration of Chaihu-Shugan-San by ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and its application to pharmacokinetic studies. J Pharm Biomed Anal. 2020; 186: 113310.

[14]

Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978; 47: 379-91.

[15]

De Winter BY, Bredenoord AJ, De Man JG, Moreels TG, Herman AG, Pelckmans PA. Effect of inhibition of inducible nitric oxide synthase and guanylyl cyclase on endotoxin-induced delay in gastric emptying and intestinal transit in mice. Shock. 2002; 18: 125-31.

[16]

Liu X, Luo M, Wang Z, Yang SJ, Su M, Wang Y, et al. Mind shift I: Fructus Aurantii - Rhizoma Chuanxiong synergistically anchors stress-induced depression-like behaviours and gastrointestinal dysmotility cluster by regulating psycho-immune-neuroendocrine network. Phytomedicine. 2024; 128: 155324.

[17]

Zhao Q, Liu J, Chen L, Gao Z, Lin M, Wang Y, et al. Phytomedicine Fructus Aurantii-derived two absorbed compounds unlock antidepressant and prokinetic multi-functions via modulating 5-HT3/GHSR. J Ethnopharmacol. 2024; 323: 117703.

[18]

Fujitsuka N, Asakawa A, Hayashi M, Sameshima M, Amitani H, Kojima S, et al. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry. 2009; 65: 748-59.

[19]

Gastaldon C, Raschi E, Kane JM, Barbui C, Schoretsanitis G. Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System. Psychother Psychosom. 2021; 90: 41-8.

[20]

Chancellor D. The depression market. Nat Rev Drug Discov. 2011; 10: 809-10.

[21]

Hawkins MA, Callahan CM, Stump TE, Stewart JC. Depressive symptom clusters as predictors of incident coronary artery disease: a 15-year prospective study. Psychosom Med. 2014; 76: 38-43.

[22]

Afridi MI, Siddiqui MA, Ansari A. Gastrointestinal somatization in males and females with depressive disorder. J Pak Med Assoc. 2009; 59: 675-9.

[23]

Norton J, Pastore M, Ancelin M, Hotopf M, Tylee A, Mann A, et al. Time-dependent cognitive and somatic symptoms of depression as predictors of new cardiac-related events in at-risk patients: the UPBEAT-UK cohort. Psychol Med. 2021; 51: 1271-8.

[24]

Bracken RM, Linnane DM, Brooks S. Plasma catecholamine and nephrine responses to brief intermittent maximal intensity exercise. Amino Acids. 2009; 36: 209-17.

[25]

Stockhorst U, Antov MI. Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review. Front Behav Neurosci. 2016; 9: 359.

[26]

Ning B, Wei Y, Luo C, Yang L, Zheng Z, Fang P, et al. Natural products targeting the gut-brain axis for the treatment of post-cardiac procedures anxiety or depression. Phytomedicine. 2026; 155: 158061.

[27]

Carney RM, Freedland KE. Depression and coronary heart disease. Nat Rev Cardiol. 2017; 14: 145-55.

[28]

Edmondson D, Newman JD, Whang W, Davidson KW. Emotional triggers in myocardial infarction: do they matter? Eur Heart J. 2013; 34: 300-6.

[29]

Li L, Yu AL, Wang ZL, Chen K, Zheng W, Zhou JJ, et al. Chaihu-Shugan-San and absorbed meranzin hydrate induce anti-atherosclerosis and behavioral improvements in high-fat diet ApoE-/- mice via anti-inflammatory and BDNF-TrkB pathway. Biomed Pharmacother. 2019; 115: 108893.

[30]

Yin X, Guven N, Dietis N. Stress-based animal models of depression: Do we actually know what we are doing? Brain Res. 2016; 1652: 30-42.

[31]

Kennedy CLM, Carter SD, Mifsud KR, Reul JMHM. Unexpected effects of metyrapone on corticosteroid receptor interaction with the genome and subsequent gene transcription in the hippocampus of male rats. J Neuroendocrinol. 2020; 32:e12820.

[32]

Trunnell ER, Carvalho C. The forced swim test has poor accuracy for identifying novel antidepressants. Drug Discov Today. 2021; 26: 2898-904.

[33]

Gururajan A, Reif A, Cryan JF, Slattery DA. The future of rodent models in depression research. Nat Rev Neurosci. 2019; 20: 686-701.

[34]

Reardon S. Rodent tests for psychiatric drugs get a rethink. Science. 2024; 383: 1279.

[35]

Gagliano G, Monteverdi A, Casali S, Laforenza U, Gandini Wheeler-Kingshott CAM, D'Angelo E, et al. Non-Linear Frequency Dependence of Neurovascular Coupling in the Cerebellar Cortex Implies Vasodilation-Vasoconstriction Competition. Cells. 2022; 11: 1047.

[36]

Huang W, Huang X, Xing Z, Qiu X, Wang Y, Fan R, et al. Meranzin hydrate induces similar effect to Fructus Aurantii on intestinal motility through activation of H1 histamine receptors. J Gastrointest Surg. 2011; 15: 87-96.

[37]

Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci. 2008; 105: 4826-31.

[38]

Salewskij K, Penninger JM. Blood Vessel Organoids for Development and Disease. Circ Res. 2023; 132: 498-510.

[39]

König P, Dedio J, Müller-Esterl W, Kummer W. Distribution of the novel eNOS-interacting protein NOSIP in the liver, pancreas, and gastrointestinal tract of the rat. Gastroenterology. 2002; 123: 314-24.

[40]

Schaum N, Lehallier B, Hahn O, Pálovics R, Hosseinzadeh S, Lee SE, et al.; Tabula Muris Consortium; Pisco AO, Karkanias J, Neff NF, Keller A, Darmanis S, Quake SR, et al. Ageing hallmarks exhibit organ-specific temporal signatures. Nature. 2020; 583: 596-602.

[41]

Codarri Deak L, Nicolini V, Hashimoto M, Karagianni M, Schwalie PC, Lauener L, et al. PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells. Nature. 2022; 610: 161-72.

[42]

Despic V, Jaffrey SR. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature. 2023; 614: 358-66.

[43]

Kubota K, Yokoyama M, Onitsuka K, Kanemura N. The investigation of an analysis method for co-activation of knee osteoarthritis utilizing normalization of peak dynamic method. Gait Posture. 2023; 101: 48-54.

[44]

Han M, Zeng D, Tan W, Chen X, Bai S, Wu Q, et al. Brain region-specific roles of brain-derived neurotrophic factor in social stress-induced depressive-like behavior. Neural Regen Res. 2025; 20: 159-73.

[45]

Vaccarino V, Badimon L, Bremner JD, Cenko E, Cubedo J, Dorobantu M, et al.; ESC Scientific Document Group Reviewers. Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. Eur Heart J. 2020; 41: 1687-96.

[46]

Greaney JL, Saunders EFH, Santhanam L, Alexander LM. Oxidative Stress Contributes to Microvascular Endothelial Dysfunction in Men and Women With Major Depressive Disorder. Circ Res. 2019; 124: 564-74.

[47]

Stone LA, Harmatz ES, Goosens KA. Ghrelin as a Stress Hormone: Implications for Psychiatric Illness. Biol Psychiatry. 2020; 88: 531-40.

[48]

Elantary R, Othman S. Role of L-carnitine in Cardiovascular Health: Literature Review. Cureus. 2024; 16: e70279.

[49]

Wang Z, Wu F, Zhou Q, Qiu Y, Zhang J, Tu Q, et al. Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice. Front Microbiol. 2022; 13: 814855.

[50]

Xie A, Ensink E, Li P, Gordevičius J, Marshall LL, George S, et al. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms. Mov Disord. 2022; 37: 1644-53.

[51]

Procházková N, Falony G, Dragsted LO, Licht TR, Raes J, Roager HM. Advancing human gut microbiota research by considering gut transit time. Gut. 2023; 72: 180-91.

[52]

Llorens-Martín M, Jurado-Arjona J, Bolós M, Pallas-Bazarra N, Ávila J. Forced swimming sabotages the morphological and synaptic maturation of newborn granule neurons and triggers a unique pro-inflammatory milieu in the hippocampus. Brain Behav Immun. 2016; 53: 242-54.

[53]

Musazzi L, Tornese P, Sala N, Popoli M. Acute or Chronic? A Stressful Question. Trends Neurosci. 2017; 40: 525-35.

[54]

Müller TD, Nogueiras R, Andermann ML, Andrews ZB, Anker SD, Argente J, et al. Ghrelin. Mol Metab. 2015; 4: 437-60.

[55]

Whitty CJM, Watt FM. Map clusters of diseases to tackle multimorbidity. Nature. 2020; 579: 494-6.

[56]

Pietzner M, Stewart ID, Raffler J, Khaw KT, Michelotti GA, Kastenmüller G, et al. Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med. 2021; 27: 471-9.

[57]

Whitney DG, Schmidt M, Hurvitz EA. Shared Physiologic Pathways Among Comorbidities for Adults With Cerebral Palsy. Front Neurol. 2021; 12: 742179.

[58]

Shabir O, Moll TA, Matuszyk MM, Eyre B, Dake MD, Berwick J, et al. Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia. Mech Ageing Dev. 2020; 192: 111361.

[59]

Claypool AL, Goldhaber-Fiebert JD, Brandeau ML. Assessing Interventions That Prevent Multiple Infectious Diseases: Simple Methods for Multidisease Modeling. Med Decis Making. 2022; 42: 436-49.

[60]

Desdín-Micó G, Soto-Heredero G, Aranda JF, Oller J, Carrasco E, Gabandé-Rodríguez E, et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science. 2020; 368: 1371-6.

[61]

Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers. 2022; 8: 48.

[62]

Yang Y, Cui Y, Sang K, Dong Y, Ni Z, Ma S, et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature. 2018; 554: 317-22.

PDF (10987KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉